drugset

drugset / Trial / NCT00191360

Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency

NCT00191360 ↗

Phase 3 Completed 68 enrolled Eli Lilly and Company

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate long-term safety of growth hormone replacement in adult patients with growth hormone deficiency

Timeline

Start: 2003-01
Primary completion: —
Completion: 2006-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Somatropin	Protein / enzyme biologic	—	—

Indications